Teleflex Incorporated (TFX) Stock Analysis
Range Bound setup
Healthcare · Medical Instruments & Supplies
Hold if already holding. Not a fresh buy at $132.74, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (5.0% away).
Teleflex provides single-use medical devices for critical care (vascular, interventional) and surgical applications globally across Americas, EMEA, and Asia segments. The company agreed to divest Acute Care, Interventional Urology, and OEM businesses for $2.0B; Jason Weidman was... Read more
Hold if already holding. Not a fresh buy at $132.74, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (5.0% away). Chart setup: RSI 49 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Score 6.0/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 72d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent Developments — Teleflex Incorporated
Latest news
- TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash - TradingView — TradingView positive
- TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash - Yahoo Finance — Yahoo Finance positive
- Teleflex stock (US8793691069): Interim CEO's routine tax withholding on RSUs - AD HOC NEWS — AD HOC NEWS neutral
- First Eagle Investment Management LLC Buys 52,300 Shares of Teleflex Incorporated $TFX - MarketBeat — MarketBeat neutral
- Strs Ohio Acquires 11,002 Shares of Teleflex Incorporated $TFX - MarketBeat — MarketBeat neutral
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 ceiling hit
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $132.74, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (5.0% away). Chart setup: RSI 49 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Target $136.88 (+3.1%), stop $123.45 (−7.5%), A.R:R -0.6:1. Score 6.0/10, moderate confidence.
Take-profit target: $136.88 (+3.1% upside). Target $136.88 (+3.1%), stop $123.45 (−7.5%), A.R:R -0.6:1. Stop-loss: $123.45.
Analyst target reached - limited upside remaining; Near 52-week high (5.0% away); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.0).
Teleflex Incorporated trades at a P/E of 1863.0 (forward 12.5). TrendMatrix value score: 6.5/10. Verdict: Hold.
17 analysts cover TFX with a consensus score of 3.4/5. Average price target: $144.
What does Teleflex Incorporated do?Teleflex provides single-use medical devices for critical care (vascular, interventional) and surgical applications...
Teleflex provides single-use medical devices for critical care (vascular, interventional) and surgical applications globally across Americas, EMEA, and Asia segments. The company agreed to divest Acute Care, Interventional Urology, and OEM businesses for $2.0B; Jason Weidman was named permanent CEO effective June 8, 2026 following the January 2026 departure of CEO Liam Kelly.